thymine has been researched along with Vomiting in 4 studies
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A novel oral agent that consists of trifluridine and tipiracil hydrochloride (TFTD) has been established as salvage-line treatment for metastatic colorectal cancer (mCRC)." | 7.83 | Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study. ( Aoyama, T; Hama, T; Inoue, A; Kawakami, K; Machida, Y; Suenaga, M; Sugisaki, T; Sugita, K; Suzuki, K; Takiguchi, T; Yamaguchi, K; Yamaguchi, T; Yokokawa, T, 2016) |
| "Evaluation demonstrated a trend toward thymidine protection of carboplatin-induced treatment-limiting thrombocytopenia." | 5.09 | Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer. ( Alberti, D; Arzoomanian, RZ; Cohen, JD; Feierabend, C; Jacobson, E; Katschinski, DM; Mehta, M; Olsen, M; Robins, HI; Tiggelaar, CL; Tutsch, K; Wilding, G, 1999) |
| "A novel oral agent that consists of trifluridine and tipiracil hydrochloride (TFTD) has been established as salvage-line treatment for metastatic colorectal cancer (mCRC)." | 3.83 | Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study. ( Aoyama, T; Hama, T; Inoue, A; Kawakami, K; Machida, Y; Suenaga, M; Sugisaki, T; Sugita, K; Suzuki, K; Takiguchi, T; Yamaguchi, K; Yamaguchi, T; Yokokawa, T, 2016) |
| " Adverse events to TAS-102 monotherapy were observed in 22 out of 23 cases (95." | 1.43 | Safety of an oral anticancer agent (trifluridine/tipiracil combination tablet) in patients with advanced and recurrent colorectal cancer. ( Asano, H; Go, M; Ito, D; Iwai, M; Kimura, M; Teramachi, H; Usami, E; Yoshimura, T, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, M | 1 |
| Go, M | 1 |
| Iwai, M | 1 |
| Ito, D | 1 |
| Asano, H | 1 |
| Usami, E | 1 |
| Teramachi, H | 1 |
| Yoshimura, T | 1 |
| Sugita, K | 1 |
| Kawakami, K | 1 |
| Yokokawa, T | 1 |
| Sugisaki, T | 1 |
| Takiguchi, T | 1 |
| Aoyama, T | 1 |
| Suzuki, K | 1 |
| Suenaga, M | 1 |
| Yamaguchi, K | 1 |
| Inoue, A | 1 |
| Machida, Y | 1 |
| Yamaguchi, T | 1 |
| Hama, T | 1 |
| Brussel, W | 1 |
| van Kuilenburg, AB | 1 |
| Janssens, PM | 1 |
| Robins, HI | 1 |
| Tutsch, K | 1 |
| Katschinski, DM | 1 |
| Jacobson, E | 1 |
| Mehta, M | 1 |
| Olsen, M | 1 |
| Cohen, JD | 1 |
| Tiggelaar, CL | 1 |
| Arzoomanian, RZ | 1 |
| Alberti, D | 1 |
| Feierabend, C | 1 |
| Wilding, G | 1 |
1 trial available for thymine and Vomiting
| Article | Year |
|---|---|
Phase I trial of intravenous thymidine and carboplatin in patients with advanced cancer.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cohort Studies; Drug Administration Schedule; Drug | 1999 |
3 other studies available for thymine and Vomiting
| Article | Year |
|---|---|
Safety of an oral anticancer agent (trifluridine/tipiracil combination tablet) in patients with advanced and recurrent colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Combinations; Female; | 2016 |
Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study.
Topics: Abdominal Pain; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemot | 2016 |
A neonate with recurrent vomiting and generalized hypotonia diagnosed with a deficiency of dihydropyrimidine dehydrogenase.
Topics: Developmental Disabilities; Dihydrouracil Dehydrogenase (NADP); Female; Homozygote; Humans; Infant; | 2006 |